HFCAS OpenIR  > 中科院强磁场科学中心
Determining Cysteines Available for Covalent Inhibition Across the Human Kinome
Zhao, Zheng1; Liu, Qingsong2; Bliven, Spencer1,3; Xie, Lei4,5; Bourne, Philip E.1,6
2017-04-13
发表期刊JOURNAL OF MEDICINAL CHEMISTRY
摘要Covalently bound protein kinase inhibitors have been frequently designed to target noncatalytic cysteines at the ATP binding site. Thus, it is important to know if a given cysteine can form a covalent bond. Here we combine a function-site interaction fingerprint method and DFT calculations to determine the potential of cysteines to form a covalent interaction with an inhibitor. By harnessing the human structural kinome, a comprehensive structure-based binding site cysteine data set was assembled. The orientation of the cysteine thiol group indicates which cysteines can potentially form covalent bonds. These covalent inhibitor easy available cysteines are located within five regions: P-loop, roof of pocket, front pocket, catalytic-2 of the catalytic loop, and DFG-3 close to the DFG peptide. In an independent test set these cysteines covered 95% of covalent kinase inhibitors. This study provides new insights into cysteine reactivity and preference which is important for the prospective development of covalent kinase inhibitors.
文章类型Article
WOS标题词Science & Technology ; Life Sciences & Biomedicine
DOI10.1021/acs.jmedchem.6b01815
关键词[WOS]TRANSITION-STATE CALCULATIONS ; KINASE INHIBITORS ; MICHAEL ADDITION ; TYROSINE KINASE ; DRUG DISCOVERY ; IRREVERSIBLE INHIBITORS ; ACCEPTOR REACTIVITY ; PSEUDOKINASE HER3 ; PROTEIN-KINASES ; LUNG-CANCER
收录类别SCI
语种英语
项目资助者Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; Intramural Research Program of the National Library of Medicine, National Institutes of Health ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Library of Medicine, National Institutes of Health(R01LM011986) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599) ; National Institute on Minority Health and Health Disparities, National Institutes of Health(G12MD007599)
WOS研究方向Pharmacology & Pharmacy
WOS类目Chemistry, Medicinal
WOS记录号WOS:000399436100018
引用统计
被引频次:89[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.hfcas.ac.cn:8080/handle/334002/33348
专题中科院强磁场科学中心
作者单位1.Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA
2.Chinese Acad Sci, High Field Magnet Lab, Hefei 230031, Anhui, Peoples R China
3.Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland
4.CUNY, Hunter Coll, Dept Comp Sci, New York, NY 10065 USA
5.CUNY, Grad Ctr, New York, NY 10016 USA
6.NIH, Off Director, Bldg 10, Bethesda, MD 20892 USA
推荐引用方式
GB/T 7714
Zhao, Zheng,Liu, Qingsong,Bliven, Spencer,et al. Determining Cysteines Available for Covalent Inhibition Across the Human Kinome[J]. JOURNAL OF MEDICINAL CHEMISTRY,2017,60(7):2879-2889.
APA Zhao, Zheng,Liu, Qingsong,Bliven, Spencer,Xie, Lei,&Bourne, Philip E..(2017).Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.JOURNAL OF MEDICINAL CHEMISTRY,60(7),2879-2889.
MLA Zhao, Zheng,et al."Determining Cysteines Available for Covalent Inhibition Across the Human Kinome".JOURNAL OF MEDICINAL CHEMISTRY 60.7(2017):2879-2889.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhao, Zheng]的文章
[Liu, Qingsong]的文章
[Bliven, Spencer]的文章
百度学术
百度学术中相似的文章
[Zhao, Zheng]的文章
[Liu, Qingsong]的文章
[Bliven, Spencer]的文章
必应学术
必应学术中相似的文章
[Zhao, Zheng]的文章
[Liu, Qingsong]的文章
[Bliven, Spencer]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。